We are live on ! Find out more

243 hedge funds and large institutions have $3.14B invested in RXO in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 84 increasing their positions, 75 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 46 (+2)

23% more capital invested

Capital invested by funds: $2.56B → $3.14B (+$588M)

15% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 27

12% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 75

2.39% more ownership

Funds ownership: 99.8%102.19% (+2.4%)

1% more funds holding

Funds holding: 241243 (+2)

92% less call options, than puts

Call options by funds: $1.22M | Put options by funds: $14.6M

Holders
243
Holders Change
+2
Holders Change %
+0.83%
% of All Funds
3.5%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
31
Increased
84
Reduced
75
Closed
27
Calls
$1.22M
Puts
$14.6M
Net Calls
-$13.4M
Net Calls Change
-$15.1M

RXO Hedge Fund Activity: Q2 2024 in Review

243 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in RXO (RXO) for Q2 2024, worth a combined $3.14B — up 23% from $2.56B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new RXO positions and 27 closed out — a net gain of 4 holders — while 84 added to existing stakes and 75 trimmed.

The largest buyer was MFN Partners, adding an estimated $35.8M. The largest seller was Fidelity Investments, cutting an estimated $14.6M.

  • 243 institutional investors held RXO (RXO) as of Q2 2024, up from 241 in Q1 2024.
  • Funds reported $3.14B of RXO stock for Q2 2024, up 23% quarter-over-quarter.
  • 31 funds opened new RXO positions in Q2 2024 and 27 closed out, a net change of +4 holders.
  • The largest RXO buyer in Q2 2024 was MFN Partners, an estimated $35.8M added.
  • The largest RXO seller in Q2 2024 was Fidelity Investments, an estimated $14.6M sold.

Based on aggregated 13F filings for Q2 2024.